Skip to main content
. Author manuscript; available in PMC: 2012 Nov 17.
Published in final edited form as: Health Aff (Millwood). 2012 Apr;31(4):750–759. doi: 10.1377/hlthaff.2011.1062

EXHIBIT 2. Patient And Disease Characteristics Of The Study Population, Study Of Medicare Beneficiaries Treated For Prostate Cancer, Selected Years 2001-07.

2001 (%)
2004 (%)
2007 (%)
Characteristic 3D-CRT
(n = 4,874)
IMRT
(n = 401)
3D-CRT
(n = 1,973)
IMRT
(n = 3,052)
3D-CRT
(n = 579)
IMRT
(n = 4,842)
AGE (YEARS)
65-69 21 19 25 23** 26 23****
70-74 38 41 34 37 33 36
75-79 31 30 27 29 26 28
80+ 10 9 13 11 15 13
RACE/ETHNLCITY
White 85 89**** 83 83** 86 82**
African American 9 3 11 10 9 10
Other 5 8 6 8 5 8
SOCIOECONOMIC STATUS
Low 54 65**** 53 56** 53 57
Medium 24 13 24 21 27 23
High 22 22 23 23 19 19
NUMBER OF COMORBIDITIES
0 66 68 64 66 59 61
1 23 21 23 23 25 25
2 or more 11 10 13 12 16 14
DISEASE CLASSIFICATION
Low risk 57 55 25 32**** 18 27****
High risk 43 45 75 68 82 73

SOURCE Authors’ analysis of linked Surveillance, Epidemiology, and End Results (SEER)-Medicare data. NOTES IMRT is intensity-modulated radiotherapy. 3D-CRT is three-dimensional conformal therapy. Chi-square tests were performed for all categorical variables. Percentages might not sum to 100 because of rounding.

**

p < 0.05

****

p < 0.001